​

CARGO Therapeutics (CRGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

CRGX Stock Forecast

CARGO Therapeutics stock forecast is as follows: an average price target of $31.00 (represents a 108.05% upside from CRGX’s last price of $14.90) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

CRGX Price Target

The average price target for CARGO Therapeutics (CRGX) is $31.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $34.00 to $28.00. This represents a potential 108.05% upside from CRGX's last price of $14.90.

CRGX Analyst Ratings

Buy

According to 2 Wall Street analysts, CARGO Therapeutics's rating consensus is 'Buy'. The analyst rating breakdown for CRGX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

CARGO Therapeutics Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 12, 2024Biren AminPiper Sandler$34.00$22.1853.29%128.19%
Jul 08, 2024Geulah LivshitsLoop Capital Markets$28.00$16.0075.00%87.92%
Jun 27, 2024Biren AminPiper Sandler$37.00$14.60153.42%148.32%
May 16, 2024Asthika GoonewardeneTruist Financial$32.00$20.9952.45%114.77%

The latest CARGO Therapeutics stock forecast, released on Sep 12, 2024 by Biren Amin from Piper Sandler, set a price target of $34.00, which represents a 53.29% increase from the stock price at the time of the forecast ($22.18), and a 128.19% increase from CRGX last price ($14.90).

CARGO Therapeutics Price Target by Period

1M3M12M
# Anlaysts--4
Avg Price Target--$32.75
Last Closing Price$14.90$14.90$14.90
Upside/Downside-100.00%-100.00%119.80%

In the current month, the average price target of CARGO Therapeutics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CARGO Therapeutics's last price of $14.90. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Sep 12, 2024Piper SandlerOverweightOverweightHold
Jul 08, 2024Chardan CapitalBuyInitialise
Jun 27, 2024Piper SandlerOverweightInitialise

CARGO Therapeutics's last stock rating was published by Piper Sandler on Sep 12, 2024. The company gave CRGX a "Overweight" rating, the same as its previous rate.

CARGO Therapeutics Financial Forecast

CARGO Therapeutics Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue---------------
Avg Forecast----$4.00M$2.00M$1.00M--------
High Forecast----$4.00M$2.00M$1.00M--------
Low Forecast----$4.00M$2.00M$1.00M--------
# Analysts----111--------
Surprise %---------------

CARGO Therapeutics's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CRGX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

CARGO Therapeutics EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts----111--------
EBITDA---------------
Avg Forecast---------------
High Forecast---------------
Low Forecast---------------
Surprise %---------------

undefined analysts predict CRGX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CARGO Therapeutics's previous annual EBITDA (undefined) of $NaN.

CARGO Therapeutics Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts----111--------
Net Income---------------
Avg Forecast$-10.62M$-15.31M$-17.68M$-23.32M$-35.51M$-44.33M$-41.71M$-41.94M$-47.73M$-45.89M$-44.67M$-44.94M$-45.60M$-52.84M$-43.53M
High Forecast$-10.62M$-15.31M$-17.68M$-23.32M$-35.51M$-44.33M$-41.71M$-41.94M$-47.73M$-45.89M$-44.67M$-38.45M$-37.22M$-52.84M$-43.53M
Low Forecast$-10.62M$-15.31M$-17.68M$-23.32M$-35.51M$-44.33M$-41.71M$-41.94M$-47.73M$-45.89M$-44.67M$-51.43M$-53.04M$-52.84M$-43.53M
Surprise %---------------

CARGO Therapeutics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CRGX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

CARGO Therapeutics SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts----111--------
SG&A---------------
Avg Forecast---------------
High Forecast---------------
Low Forecast---------------
Surprise %---------------

CARGO Therapeutics's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CRGX last annual SG&A of $NaN (undefined).

CARGO Therapeutics EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts----111--------
EPS---------------
Avg Forecast$-0.22$-0.32$-0.37$-0.49$-0.74$-0.93$-0.88$-0.88$-1.00$-0.96$-0.94$-0.94$-0.96$-1.11$-1.00
High Forecast$-0.22$-0.32$-0.37$-0.49$-0.74$-0.93$-0.88$-0.88$-1.00$-0.96$-0.94$-0.81$-0.78$-1.11$-1.00
Low Forecast$-0.22$-0.32$-0.37$-0.49$-0.74$-0.93$-0.88$-0.88$-1.00$-0.96$-0.94$-1.08$-1.11$-1.11$-1.00
Surprise %---------------

According to undefined Wall Street analysts, CARGO Therapeutics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CRGX previous annual EPS of $NaN (undefined).

CRGX Forecast FAQ

Is CARGO Therapeutics a good buy?

Yes, according to 2 Wall Street analysts, CARGO Therapeutics (CRGX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of CRGX's total ratings.

What is CRGX's price target?

CARGO Therapeutics (CRGX) average price target is $31 with a range of $28 to $34, implying a 108.05% from its last price of $14.9. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CARGO Therapeutics stock go up soon?

According to Wall Street analysts' prediction for CRGX stock, the company can go up by 108.05% (from the last price of $14.9 to the average price target of $31), up by 128.19% based on the highest stock price target, and up by 87.92% based on the lowest stock price target.

Can CARGO Therapeutics stock reach $20?

CRGX's average twelve months analyst stock price target of $31 supports the claim that CARGO Therapeutics can reach $20 in the near future.

What are CARGO Therapeutics's analysts' financial forecasts?

CARGO Therapeutics's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $7M (high $7M, low $7M), average EBITDA is $0 (high $0, low $0), average net income is $-163M (high $-163M, low $-163M), average SG&A $0 (high $0, low $0), and average EPS is $-3.43 (high $-3.43, low $-3.43). CRGX's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-66.94M (high $-66.94M, low $-66.94M), average SG&A $0 (high $0, low $0), and average EPS is $-1.404 (high $-1.404, low $-1.404).